Therapeutic area intelligence for Behavioral Intervention with 3 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals: 3
Catalysts: 0
Companies: 0

Companies

No related entities indexed yet.

Assets

BSAFE →

Michigan →

Pilot →

Recent signals(3)

ClinicalAugust 6, 2026

BSAFE Trial Aims to Reduce Overdose Risk in Stimulant Users with Fentanyl Education

The BSAFE trial is testing a brief intervention aimed at reducing overdose risks among stimulant users potentially exposed to fentanyl.

ClinicalAugust 1, 2026

Michigan Men's Diabetes Project III: Pilot Trial for Black Men with Type 2 Diabetes

A pilot randomized clinical trial is set to recruit 80 Black men with type 2 diabetes to evaluate a combined intervention of cognitive behavioral therapy and guided exercise.

ClinicalJune 28, 2026

Pilot Study on Behavioral Program for Weight Loss After GLP-1 Discontinuation

A pilot randomized factorial trial is assessing a multi-component behavioral intervention for weight loss maintenance after discontinuation of GLP-1 and anti-obesity medications.

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

Diabetes →

Obesity →

Substance Use Disorder →

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.